P1101 Treatment Meets Phase 3 Primary End Point in Essential Thrombocythemia
P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the primary end goal of SURPASS-ET.
P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the primary end goal of SURPASS-ET.
Stereotactic body radiation therapy combined with Nexavar showed a clinically important improvement in overall survival in locally advanced hepatocellular carcinoma.
18F-DOPA PET−guided, dose-escalated, hypofractionated proton beam therapy led to improved OS in older patients with newly diagnosed glioblastoma.
Explore transformational leadership principles, from authentic vision-setting to fostering growth and creativity. Learn how to balance transactional and transformational styles to inspire teams and navigate…
A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and potential side effects.
The targeted therapy appeared to be safe and effective in treating patients with KRAS G12C mutated pancreatic cancer, according to results from a recent study.
When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort in listening to music.
The proportion of patients who have been diagnosed with cancer at an early stage in England is at its highest ever level
Read about the results of a RCN Northern Ireland consultation on the 2024-25 pay offer for nurses and other Health and Social Care staff.
Information, Tools and Support in Key Therapeutic Areas The quality care you provide to your patients stems from your dedication to treating them as a…
Read about the announcement of the theme for 2025’s International Nurses Day, which will focus on nurse wellbeing.